Global Poliomyelitis Vaccine Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-poliomyelitis-vaccine-market-research-report-2023status-n-outlook_en.gif)
Report Overview:
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The Global Poliomyelitis Vaccine Market Size was estimated at USD 730.12 million in 2023 and is projected to reach USD 836.85 million by 2029, exhibiting a CAGR of 2.30% during the forecast period.
This report provides a deep insight into the global Poliomyelitis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Poliomyelitis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Poliomyelitis Vaccine market in any manner.
Global Poliomyelitis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Market Segmentation (by Type)
Poliomyelitis Vaccine ?
Poliomyelitis Vaccine ?
Poliomyelitis Vaccine ?
Oral Poliomyelitis Vaccine
Market Segmentation (by Application)
VAPP
VDPV
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliomyelitis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
The Global Poliomyelitis Vaccine Market Size was estimated at USD 730.12 million in 2023 and is projected to reach USD 836.85 million by 2029, exhibiting a CAGR of 2.30% during the forecast period.
This report provides a deep insight into the global Poliomyelitis Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Poliomyelitis Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Poliomyelitis Vaccine market in any manner.
Global Poliomyelitis Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Market Segmentation (by Type)
Poliomyelitis Vaccine ?
Poliomyelitis Vaccine ?
Poliomyelitis Vaccine ?
Oral Poliomyelitis Vaccine
Market Segmentation (by Application)
VAPP
VDPV
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Poliomyelitis Vaccine Market
- Overview of the regional outlook of the Poliomyelitis Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Poliomyelitis Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Poliomyelitis Vaccine
1.2 Key Market Segments
1.2.1 Poliomyelitis Vaccine Segment by Type
1.2.2 Poliomyelitis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOMYELITIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliomyelitis Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Poliomyelitis Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOMYELITIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Poliomyelitis Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Poliomyelitis Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Poliomyelitis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Poliomyelitis Vaccine Sales Sites, Area Served, Product Type
3.6 Poliomyelitis Vaccine Market Competitive Situation and Trends
3.6.1 Poliomyelitis Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Poliomyelitis Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 POLIOMYELITIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Poliomyelitis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOMYELITIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Poliomyelitis Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Poliomyelitis Vaccine Price by Type (2019-2024)
7 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliomyelitis Vaccine Market Sales by Application (2019-2024)
7.3 Global Poliomyelitis Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
8 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Poliomyelitis Vaccine Sales by Region
8.1.1 Global Poliomyelitis Vaccine Sales by Region
8.1.2 Global Poliomyelitis Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Poliomyelitis Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Poliomyelitis Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Poliomyelitis Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Poliomyelitis Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Poliomyelitis Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Poliomyelitis Vaccine Basic Information
9.1.2 GSK Poliomyelitis Vaccine Product Overview
9.1.3 GSK Poliomyelitis Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Poliomyelitis Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Sanofi-Pasteur
9.2.1 Sanofi-Pasteur Poliomyelitis Vaccine Basic Information
9.2.2 Sanofi-Pasteur Poliomyelitis Vaccine Product Overview
9.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Product Market Performance
9.2.4 Sanofi-Pasteur Business Overview
9.2.5 Sanofi-Pasteur Poliomyelitis Vaccine SWOT Analysis
9.2.6 Sanofi-Pasteur Recent Developments
9.3 Merck
9.3.1 Merck Poliomyelitis Vaccine Basic Information
9.3.2 Merck Poliomyelitis Vaccine Product Overview
9.3.3 Merck Poliomyelitis Vaccine Product Market Performance
9.3.4 Merck Poliomyelitis Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Crucell
9.4.1 Crucell Poliomyelitis Vaccine Basic Information
9.4.2 Crucell Poliomyelitis Vaccine Product Overview
9.4.3 Crucell Poliomyelitis Vaccine Product Market Performance
9.4.4 Crucell Business Overview
9.4.5 Crucell Recent Developments
9.5 China National Biotech Group
9.5.1 China National Biotech Group Poliomyelitis Vaccine Basic Information
9.5.2 China National Biotech Group Poliomyelitis Vaccine Product Overview
9.5.3 China National Biotech Group Poliomyelitis Vaccine Product Market Performance
9.5.4 China National Biotech Group Business Overview
9.5.5 China National Biotech Group Recent Developments
9.6 Eli Lilly
9.6.1 Eli Lilly Poliomyelitis Vaccine Basic Information
9.6.2 Eli Lilly Poliomyelitis Vaccine Product Overview
9.6.3 Eli Lilly Poliomyelitis Vaccine Product Market Performance
9.6.4 Eli Lilly Business Overview
9.6.5 Eli Lilly Recent Developments
10 POLIOMYELITIS VACCINE MARKET FORECAST BY REGION
10.1 Global Poliomyelitis Vaccine Market Size Forecast
10.2 Global Poliomyelitis Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Poliomyelitis Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Poliomyelitis Vaccine Market Size Forecast by Region
10.2.4 South America Poliomyelitis Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Poliomyelitis Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Poliomyelitis Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Poliomyelitis Vaccine by Type (2025-2030)
11.1.2 Global Poliomyelitis Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Poliomyelitis Vaccine by Type (2025-2030)
11.2 Global Poliomyelitis Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Poliomyelitis Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Poliomyelitis Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Poliomyelitis Vaccine
1.2 Key Market Segments
1.2.1 Poliomyelitis Vaccine Segment by Type
1.2.2 Poliomyelitis Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POLIOMYELITIS VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Poliomyelitis Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Poliomyelitis Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POLIOMYELITIS VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Poliomyelitis Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Poliomyelitis Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Poliomyelitis Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Poliomyelitis Vaccine Sales Sites, Area Served, Product Type
3.6 Poliomyelitis Vaccine Market Competitive Situation and Trends
3.6.1 Poliomyelitis Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Poliomyelitis Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 POLIOMYELITIS VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Poliomyelitis Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POLIOMYELITIS VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Poliomyelitis Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Poliomyelitis Vaccine Price by Type (2019-2024)
7 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Poliomyelitis Vaccine Market Sales by Application (2019-2024)
7.3 Global Poliomyelitis Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
8 POLIOMYELITIS VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Poliomyelitis Vaccine Sales by Region
8.1.1 Global Poliomyelitis Vaccine Sales by Region
8.1.2 Global Poliomyelitis Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Poliomyelitis Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Poliomyelitis Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Poliomyelitis Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Poliomyelitis Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Poliomyelitis Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GSK
9.1.1 GSK Poliomyelitis Vaccine Basic Information
9.1.2 GSK Poliomyelitis Vaccine Product Overview
9.1.3 GSK Poliomyelitis Vaccine Product Market Performance
9.1.4 GSK Business Overview
9.1.5 GSK Poliomyelitis Vaccine SWOT Analysis
9.1.6 GSK Recent Developments
9.2 Sanofi-Pasteur
9.2.1 Sanofi-Pasteur Poliomyelitis Vaccine Basic Information
9.2.2 Sanofi-Pasteur Poliomyelitis Vaccine Product Overview
9.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Product Market Performance
9.2.4 Sanofi-Pasteur Business Overview
9.2.5 Sanofi-Pasteur Poliomyelitis Vaccine SWOT Analysis
9.2.6 Sanofi-Pasteur Recent Developments
9.3 Merck
9.3.1 Merck Poliomyelitis Vaccine Basic Information
9.3.2 Merck Poliomyelitis Vaccine Product Overview
9.3.3 Merck Poliomyelitis Vaccine Product Market Performance
9.3.4 Merck Poliomyelitis Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Crucell
9.4.1 Crucell Poliomyelitis Vaccine Basic Information
9.4.2 Crucell Poliomyelitis Vaccine Product Overview
9.4.3 Crucell Poliomyelitis Vaccine Product Market Performance
9.4.4 Crucell Business Overview
9.4.5 Crucell Recent Developments
9.5 China National Biotech Group
9.5.1 China National Biotech Group Poliomyelitis Vaccine Basic Information
9.5.2 China National Biotech Group Poliomyelitis Vaccine Product Overview
9.5.3 China National Biotech Group Poliomyelitis Vaccine Product Market Performance
9.5.4 China National Biotech Group Business Overview
9.5.5 China National Biotech Group Recent Developments
9.6 Eli Lilly
9.6.1 Eli Lilly Poliomyelitis Vaccine Basic Information
9.6.2 Eli Lilly Poliomyelitis Vaccine Product Overview
9.6.3 Eli Lilly Poliomyelitis Vaccine Product Market Performance
9.6.4 Eli Lilly Business Overview
9.6.5 Eli Lilly Recent Developments
10 POLIOMYELITIS VACCINE MARKET FORECAST BY REGION
10.1 Global Poliomyelitis Vaccine Market Size Forecast
10.2 Global Poliomyelitis Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Poliomyelitis Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Poliomyelitis Vaccine Market Size Forecast by Region
10.2.4 South America Poliomyelitis Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Poliomyelitis Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Poliomyelitis Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Poliomyelitis Vaccine by Type (2025-2030)
11.1.2 Global Poliomyelitis Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Poliomyelitis Vaccine by Type (2025-2030)
11.2 Global Poliomyelitis Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Poliomyelitis Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Poliomyelitis Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Poliomyelitis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Poliomyelitis Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Poliomyelitis Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
Table 10. Global Market Poliomyelitis Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Poliomyelitis Vaccine Sales Sites and Area Served
Table 12. Manufacturers Poliomyelitis Vaccine Product Type
Table 13. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Poliomyelitis Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliomyelitis Vaccine Market Challenges
Table 22. Global Poliomyelitis Vaccine Sales by Type (Kilotons)
Table 23. Global Poliomyelitis Vaccine Market Size by Type (M USD)
Table 24. Global Poliomyelitis Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Poliomyelitis Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Poliomyelitis Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Poliomyelitis Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Poliomyelitis Vaccine Sales (Kilotons) by Application
Table 30. Global Poliomyelitis Vaccine Market Size by Application
Table 31. Global Poliomyelitis Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Poliomyelitis Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Poliomyelitis Vaccine Market Share by Application (2019-2024)
Table 35. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Poliomyelitis Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Poliomyelitis Vaccine Basic Information
Table 44. GSK Poliomyelitis Vaccine Product Overview
Table 45. GSK Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Poliomyelitis Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Sanofi-Pasteur Poliomyelitis Vaccine Basic Information
Table 50. Sanofi-Pasteur Poliomyelitis Vaccine Product Overview
Table 51. Sanofi-Pasteur Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi-Pasteur Business Overview
Table 53. Sanofi-Pasteur Poliomyelitis Vaccine SWOT Analysis
Table 54. Sanofi-Pasteur Recent Developments
Table 55. Merck Poliomyelitis Vaccine Basic Information
Table 56. Merck Poliomyelitis Vaccine Product Overview
Table 57. Merck Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Poliomyelitis Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Crucell Poliomyelitis Vaccine Basic Information
Table 62. Crucell Poliomyelitis Vaccine Product Overview
Table 63. Crucell Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Crucell Business Overview
Table 65. Crucell Recent Developments
Table 66. China National Biotech Group Poliomyelitis Vaccine Basic Information
Table 67. China National Biotech Group Poliomyelitis Vaccine Product Overview
Table 68. China National Biotech Group Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. China National Biotech Group Business Overview
Table 70. China National Biotech Group Recent Developments
Table 71. Eli Lilly Poliomyelitis Vaccine Basic Information
Table 72. Eli Lilly Poliomyelitis Vaccine Product Overview
Table 73. Eli Lilly Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Recent Developments
Table 76. Global Poliomyelitis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Poliomyelitis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Poliomyelitis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Poliomyelitis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Poliomyelitis Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Poliomyelitis Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Poliomyelitis Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Poliomyelitis Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Poliomyelitis Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Poliomyelitis Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Poliomyelitis Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Poliomyelitis Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Poliomyelitis Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
Table 10. Global Market Poliomyelitis Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Poliomyelitis Vaccine Sales Sites and Area Served
Table 12. Manufacturers Poliomyelitis Vaccine Product Type
Table 13. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Poliomyelitis Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Poliomyelitis Vaccine Market Challenges
Table 22. Global Poliomyelitis Vaccine Sales by Type (Kilotons)
Table 23. Global Poliomyelitis Vaccine Market Size by Type (M USD)
Table 24. Global Poliomyelitis Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Poliomyelitis Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Poliomyelitis Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Poliomyelitis Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Poliomyelitis Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Poliomyelitis Vaccine Sales (Kilotons) by Application
Table 30. Global Poliomyelitis Vaccine Market Size by Application
Table 31. Global Poliomyelitis Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Poliomyelitis Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Poliomyelitis Vaccine Market Share by Application (2019-2024)
Table 35. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Poliomyelitis Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Poliomyelitis Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Poliomyelitis Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. GSK Poliomyelitis Vaccine Basic Information
Table 44. GSK Poliomyelitis Vaccine Product Overview
Table 45. GSK Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GSK Business Overview
Table 47. GSK Poliomyelitis Vaccine SWOT Analysis
Table 48. GSK Recent Developments
Table 49. Sanofi-Pasteur Poliomyelitis Vaccine Basic Information
Table 50. Sanofi-Pasteur Poliomyelitis Vaccine Product Overview
Table 51. Sanofi-Pasteur Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sanofi-Pasteur Business Overview
Table 53. Sanofi-Pasteur Poliomyelitis Vaccine SWOT Analysis
Table 54. Sanofi-Pasteur Recent Developments
Table 55. Merck Poliomyelitis Vaccine Basic Information
Table 56. Merck Poliomyelitis Vaccine Product Overview
Table 57. Merck Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Poliomyelitis Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Crucell Poliomyelitis Vaccine Basic Information
Table 62. Crucell Poliomyelitis Vaccine Product Overview
Table 63. Crucell Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Crucell Business Overview
Table 65. Crucell Recent Developments
Table 66. China National Biotech Group Poliomyelitis Vaccine Basic Information
Table 67. China National Biotech Group Poliomyelitis Vaccine Product Overview
Table 68. China National Biotech Group Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. China National Biotech Group Business Overview
Table 70. China National Biotech Group Recent Developments
Table 71. Eli Lilly Poliomyelitis Vaccine Basic Information
Table 72. Eli Lilly Poliomyelitis Vaccine Product Overview
Table 73. Eli Lilly Poliomyelitis Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Recent Developments
Table 76. Global Poliomyelitis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 77. Global Poliomyelitis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 78. North America Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 79. North America Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 80. Europe Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 81. Europe Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 82. Asia Pacific Poliomyelitis Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 83. Asia Pacific Poliomyelitis Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 84. South America Poliomyelitis Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 85. South America Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 86. Middle East and Africa Poliomyelitis Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 87. Middle East and Africa Poliomyelitis Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 88. Global Poliomyelitis Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 89. Global Poliomyelitis Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 90. Global Poliomyelitis Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 91. Global Poliomyelitis Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 92. Global Poliomyelitis Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Poliomyelitis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliomyelitis Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Poliomyelitis Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Poliomyelitis Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliomyelitis Vaccine Market Size by Country (M USD)
Figure 11. Poliomyelitis Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Poliomyelitis Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Poliomyelitis Vaccine Market Share by Type
Figure 18. Sales Market Share of Poliomyelitis Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Poliomyelitis Vaccine by Type in 2023
Figure 20. Market Size Share of Poliomyelitis Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Poliomyelitis Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Poliomyelitis Vaccine Market Share by Application
Figure 24. Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Poliomyelitis Vaccine Sales Market Share by Application in 2023
Figure 26. Global Poliomyelitis Vaccine Market Share by Application (2019-2024)
Figure 27. Global Poliomyelitis Vaccine Market Share by Application in 2023
Figure 28. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Poliomyelitis Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Poliomyelitis Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Poliomyelitis Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region in 2023
Figure 44. China Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Poliomyelitis Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Poliomyelitis Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Poliomyelitis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Poliomyelitis Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Poliomyelitis Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Poliomyelitis Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Poliomyelitis Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Poliomyelitis Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Poliomyelitis Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Poliomyelitis Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Poliomyelitis Vaccine Market Size by Country (M USD)
Figure 11. Poliomyelitis Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Poliomyelitis Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Poliomyelitis Vaccine Market Share by Type
Figure 18. Sales Market Share of Poliomyelitis Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Poliomyelitis Vaccine by Type in 2023
Figure 20. Market Size Share of Poliomyelitis Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Poliomyelitis Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Poliomyelitis Vaccine Market Share by Application
Figure 24. Global Poliomyelitis Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Poliomyelitis Vaccine Sales Market Share by Application in 2023
Figure 26. Global Poliomyelitis Vaccine Market Share by Application (2019-2024)
Figure 27. Global Poliomyelitis Vaccine Market Share by Application in 2023
Figure 28. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Poliomyelitis Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Poliomyelitis Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Poliomyelitis Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region in 2023
Figure 44. China Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Poliomyelitis Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Poliomyelitis Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Poliomyelitis Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Poliomyelitis Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Poliomyelitis Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Poliomyelitis Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Poliomyelitis Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Poliomyelitis Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Poliomyelitis Vaccine Market Share Forecast by Application (2025-2030)